Mayo Clinic Licenses IP from Qiagen to Develop PCR Test for TB Speciation

The new test will be based on real-time PCR using fluorescence resonance energy transfer probes for detection.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.